© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
August 06, 2021
Experts in HIV provide closing thoughts on the future of PrEP, including improvement of uptake and addressing access disparities.
August 05, 2021
Key opinion leaders in HIV describe factors to consider when evaluating which patients may benefit from long-acting injectable PrEP therapies.
August 04, 2021
A multidisciplinary panel of experts discuss pipeline medications for PrEP and effects of the USPSTF grading on emerging therapies.
July 28, 2021
Experts in HIV provide insight into the Grade A recommendation for HIV PrEP by the U.S. Preventive Services Task Force (USPSTF) and its impact on patients, clinicians, and payers.
Key opinion leaders in HIV discuss nonadherence to HIV PrEP and methods to address patient “walk away.”
July 21, 2021
Ian Frank, MD and Jeffrey Crowley, MPH provide insight into engaging clinicians for increased assessment of patients for PrEP.
Experts in HIV discuss methods to address the low rate of HIV PrEP uptake among at-risk individuals.
July 14, 2021
A multidisciplinary panel of experts discuss challenges to monitoring patient adherence and persistence to HIV PrEP.
Ian Frank, MD and Jeffrey Crowley, MPH address HIV PrEP adherence and persistence issues in the clinical practice setting.
July 07, 2021
Experts in HIV provide insight into payer coverage of HIV PrEP and patient barriers for receiving PrEP.